Home

Jay R. Luly, President and CEO: Enanta Pharmaceuticals ENTA Sell · Filed 23/03/14

Trade details

Type
Insider sale
Amount
$709,056.19
Shares · price
15,649 sh · $45.31 a share
Held after
821,376 sh
Trade date
23/03/13
Filed
23/03/14
Days to filing
1 days

Sold 1.9% of holdings

Share of holding sold
1.9%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/11~23/04/12

Jay R. Luly's recent trades

  • Jay R. Luly

    SellEnanta Pharmaceuticals

    $67.5K

    Filed 25/12/05

  • Jay R. Luly

    Planned saleEnanta Pharmaceuticals

    $67.5K

    Filed 25/12/05

  • Jay R. Luly

    BuyEnanta Pharmaceuticals

    $256.1K

    Filed 25/02/12

  • Jay R. Luly

    Sell10b5-1 planEnanta Pharmaceuticals

    $41.4K

    Filed 24/12/10

  • Jay R. Luly

    SellEnanta Pharmaceuticals

    $69.6K

    Filed 23/12/06

Jay R. Luly, CEO — sold $709.1K of Enanta Pharmaceuticals ENTA · 1.9% of holdings | Whalegun